The actions of 5-methoxytryptamine (5-MeOT), N,N-dimethyltryptamine (DMT), 5-hydroxy-N,N-dimethyltryptamine (bufotenine, 5-HODMT) and 5-methoxy-N,Ndimethyltryptamine (5-MeODMT), and their interactions with 5-hydroxytryptamine (5-HT), acetylcholine, (-)-noradrenaline, and glutamate were studied by microiontophoresis on single neurones in the brain stem of rats anaesthetized with urethane or decerebrate cats. 2 Like D-lysergic acid diethylamide (LSD 25) the three psychotomimetic derivatives (DMT, 5-HODMT, 5-MeODMT) specifically antagonized 5-HT excitations of single neurones, but the non-psychotomimetic 5-MeOT had no antagonistic effects. 3 In contrast to LSD 25, the psychotomimetic tryptamines only rarely antagonized glutamate effects, indicating that the excitatory 5-HT receptors and the glutamate receptors on the same neurones may be closely related spatially, but are separate. 4 The methylated tryptamine derivatives were able to mimic the actions of 5-HT on neurones. The non-psychotomimetic 5-MeOT was most potent in this respect, while the other three derivatives which are psychotomimetic, were less active. 5 The 5-HT mimicking actions of 5-MeOT were the same in rats pretreated with p-chlorophenylalanine or reserpine as in untreated rats. It therefore seems that the 5-HT mimicking actions are unlikely to be due to release of 5-HT, but are due to direct actions on 5-HT receptors. 6 The evidence presented supports the hypothesis that LSD-like psychotomimetics act by an antagonism of 5-HT in the lower brain stem, and is not compatible with the suggestion that the psychotomimetic action of these drugs is related to 5-HT receptor stimulation.
Introduction
In a previous study of the actions of three derivatives of lysergic acid as antagonists to microiontophoretically applied 5-hydroxytryptamine (5-HT) and other putative transmitters on brain stem neurones (Boakes, Bradley, Briggs & Dray, 1970) , evidence was obtained suggesting that the basis for the psychotomimetic action of D-lysergic acid diethylamide (LSD 25) might be related to its antagonism to the excitatory effects of 5-HT and glutamate. Such an action by LSD 25 on the brain stem reticular formation, related to the afferent collateral input (Bradley & Key, 1958) which appears to be concerned with the filtering and integration of sensory information (Key, 1965) , may account for the distortions of perception induced by this drug. On the other hand, evidence from other studies has been interpreted as indicating that the action of LSD 25 and other agents with LSD-like behavioural effects is to stimulate 5-HT receptors in the CNS, i.e. to mimic rather than block 5-HT effects (Anden, Corrodi, Fuxe & Hokfelt, 1968; Aghajanian, Foote & Sheard, 1968 Anden, Corrodi & Fuxe, 1971; Fuxe, Holmstedt & Jonsson, 1972; Aghajanian, 1972) .
Further evidence to elucidate these two possibilities seemed desirable and the data presented here represent the results of a study of the actions on single neurones, in the brain stem of both cats and rats, of four methylated tryptamine derivatives. In addition, in order to determine whether some of the effects observed might have been due to release of 5-HT from presynaptic sites, experiments were carried out on rats pretreated with either reserpine or p-chlorophenylalanine (PCPA).
Of the four methylated tryptamines studied, one, 5-methoxytryptamine (5-MeOT), is not psychotomimetic (Mashkovskii & Arutyunyan, 1964; Mashkovskii & Roshchina, 1964; Takeo & Himwich, 1967) while the other three are all reported to be psychotomimetic; they are N,Ndimethyltryptamine (DMT), 5-hydroxy-N,Ndimethyltryptamine (bufotenine, 5-HODMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) (Szara, 1957; Gessner, 1970; Shulgin, 1970) . There are some doubts about the psychotomimetic activity of bufotenine (Fabing & Hawkins, 1956; Turner & Merlis, 1959) which may be related to the relatively low penetration of the drug into the brain (Sanders & Bush, 1967) . However, it has been reported that bufotenine is at least as active as 5-MeODMT in certain animal behaviour tests when it is administered by intraventricular infusion, thus bypassing the blood brain barrier (Mandell, Buckingham & Segal, 1971) .
Some of the results given in this paper have been presented in a communication at a meeting of the British Pharmacological Society (Briggs, 1972) .
Methods
Both cats and rats were used in this investigation as experimental subjects. The initial experimental procedures were carried out on unanaesthetized decerebrate cats but later, rats were also used as this species was better able to tolerate drug pretreatment (e.g. reserpine and PCPA).
Adult cats of either sex were decerebrated, and the medial portions of the cerebellum removed under Fluothane anaesthesia (Bradley, Dhawan & Wolstencroft, 1966 Glass five-barrelled micropipettes were inserted into the brain stem through the floor of the fourth ventricle, and used to record extracellular neuronal activity and to eject drugs in the vicinity of the cells. Only spontaneously active cells were studied, most of which were located in the region 2-6 mm rostral to the obex and up to 2.0 mm lateral to the midline in the cat, and 0.5-3.5 mm rostral to the obex and up to 2.0 mm lateral to the midline in the rat, avoiding the midline itself. Neuronal activity was amplified and counted conventionally and the firing rates were plotted as mean frequencies in spikes/s, in successive 5 s epochs. The micropipettes had overall tip diameters of 4-10 ,um. The recording barrel contained 4 M NaCl and usually one other barrel contained 1 M NaCl to determine the effects of current alone. The other three barrels contained respectively aqueous solutions of one of the methylated tryptamines, 5-hydroxytryptamine, and another putative transmitter substance. The following drugs were used: 5-methoxytryptamine hydrochloride (Sigma); N,N-dimethyltryptamine bioxalate (Koch-Light); The actions of all four compounds were complex: on some neurones they had agonistic actions while on others they antagonized the actions of putative transmitters. All mimicked the actions of 5-HT, although the extent to which they did so varied considerably. The actions of the tryptamine derivatives, compared with the actions of 5-HT on the same neurones in the cat and rat, are shown in Tables 1 and 2 respectively and are illustrated in observed between the effects of the methylated tryptamines and the effects of other putative transmitters applied to the same neurone. The actions of these compounds in mimicking 5-HT were usually weaker than those of 5-HT; that is, larger iontophoretic currents or longer application (Figures la and 2) . Furthermore, the time courses of the effects were usually longer than those of 5-HT effects. However, the transport numbers of these tryptamine derivatives have not been determined, and the observed differences in apparent potencies and time courses may reflect differences in transport numbers and diffusion rates. 
5-Methoxytryptamine

Responses
The effects of this substance were tested on 25 same neurones in the cat and 120 in the rat. As with M 5-HT, excitation was the predominant effect, although some selection bias is likely, since excitations were easier to study. The actions of 5-MeOT 19/25 76 closely followed those of 5-HT (Tables 1 and 2 This compound was tested on 17 neu and 55 neurones in rats. In the ca neurones, which were affected by similarly affected by 5-HODMT, and of 54 effects were similar. The e HODMT are summarized in Tables 1  examples are (bufotenine, irones in cats Lt, 11 of 15 5-HT, were in the rat 27 ffects of 5-I and 2, and 58 in the rat. The two compounds had opposite effects on about half of the neurones on which mimicking effects were not observed, and 5-MeODMT did not affect the rest. The effects of 5-MeODMT in cat and rat are compared with those of 5-HT in Tables 1 and 2, control responses on four different neurones. In the rat, the excitatory effects of 5-HT were 
Discussion
Certain effects of LSD and other drugs with LSD-like actions (including DMT, bufotenine and 5-MeODMT) appear to be due to actions in the pons and medulla (Bradley & Key, 1958; Schweigerdt & Himwich, 1964; Key, 1965; Schweigerdt, Stewart & Himwich, 1966; Takeo & Himwich, 1967) . In this part of the brain, 5-HT has mainly excitatory effects, both in the raphe nuclei (Couch, 1970) and in the reticular formation (Boakes et al., 1970; Bradley & Dray, 1972 ; present investigation); more rostrally, in the mesencephalon, the effects of 5-HT are mainly inhibitory, both in the raphe nuclei (Aghajanian, Haigler & Bloom, 1972) and in the reticular formation (Straschill & Perwein, 1971 ) . Only the excitatory effects of 5-HT were found to be antagonized by LSD. Antagonism of 5-HT excitation by LSD has been observed in the cortex (I) a.U ( Roberts & Straughan, 1967) , the reticular formation of the pons and medulla (Boakes et al., 1970) , and the pontine raphe nuclei (Couch, 1970) . There is evidence for a serotoninergic excitatory synaptic input to the pontine raphe, and LSD blocks both synaptic excitation and the excitations produced by microiontophoretically applied 5-HT (Couch, 1970; Bloom, Hoffer, Siggins, Barker & Nicoll, 1972) . The results presented here offer further support to the hypothesis that the mode of action of drugs with psychotomimetic actions similar to those of LSD is related to an ability to antagonize the excitatory effects of 5-HT. The three tryptamine 23 derivatives which have been reported to have LSD-like psychotomimetic activity, DMT, 5-HODMT, and 5-MeODMT, were found to antagonize 5-HT excitations (Table 4) , whereas the non-psychotomimetic 5-MeOT did not. The antagonism of 5-HT excitations by these compounds was less specific than that observed previously with LSD; other agents were also antagonized, but the 5-HT antagonism was greater, both on individual neurones and in terms of the proportions of neurones affected, and was also the most consistent effect of the three active derivatives.
The most striking difference between the psychotomimetic tryptamine derivatives and LSD is in the effect on glutamate excitation of neurones which 5-HT excites. LSD always antagonized glutamate excitation of neurones which 5-HT also excited (Boakes et al., 1970) , but the tryptamine derivatives only rarely affected the action of glutamate. This difference may mean that the receptors for 5-HT and glutamate on these neurones are different but are closely related spatially, so that LSD, in occupying 5-HT excitatory receptors, overlaps the glutamate receptor sites, whereas the tryptamines do not. The ability of LSD to antagonize two excitant transmitters on the 5-HT sensitive neurones may contribute to its much higher psychotomimetic potency than those of the tryptamine derivatives. LSD rarely, if ever, antagonizes specifically the inhibitory effects of 5-HT, whether it is iontophoretically applied (Krnjevic & Phillis, 1963; Bloom, Costa & Salmoiraghi, 1964; Legge, Randic & Straughan, 1966; Roberts & Straughan, 1967; Boakes et al., 1970) or released from presumed serotoninergic synapses .
Evidence from fluorescence histochemical studies has indicated that LSD and methylated tryptamine psychotomimetics may act by mimicking the actions of 5-HT (Anden et al., 1968 (Anden et al., , 1971 Fuxe et al., 1972) . The reduced turnover of 5-HT in 5-HT containing neurones was suggested to be due to an inhibitory feedback loop, activated when these hallucinogens stimulate 5-HT receptors. An inhibitory feedback acting on raphe neurones, activated by stimulation of 5-HT receptors, has also been suggested as a mechanism for the inhibitory action of LSD on raphe neurones (Aghajanian et al., 1968 (Aghajanian et al., , 1970 Aghajanian, 1972; Samanin, Valzelli & Gumulka, 1972) . More recently, LSD has been shown to have a direct inhibitory action on midbrain raphe neurones and also to block the excitatory actions of 5-HT on pontine raphe neurones (Couch, 1970) . Both of these actions would presumably reduce turnover of 5-HT by reducing raphe cell activity, but the possibility of negative feedback following 5-HT receptor stimulation cannot yet be excluded. Mimicking of 5-HT excitatory effects has not been observed with LSD (Roberts & Straughan, 1967; Boakes et al., 1970) , and in the present study, the most potent mimicker of 5-HT excitation was the nonpsychotomimetic 5-MeOT, while the other compounds, with psychotomimetic effects, were less active in mimicking 5-HT excitation. The lack of correlation between mimicking of 5-HT excitation and psychotomimetic activity appears to exclude this effect as a possible mode of action. LSD and LSD-like drugs do, however, appear to have some effects which are similar to the effects of increasing 5-HT activity in the CNS (Anden et al., 1968 (Anden et al., , 1971 Fuxe et al., 1972) . LSD has frequently been reported to inhibit neurones which 5-HT inhibits (Curtis & Davis, 1962; Phillis, Tebecis & York, 1967; Aghajanian et al., 1972) , although the 'mimicking' of 5-HT inhibitory effects by LSD and psychotomimetic tryptamines is not a universal finding (Boakes et al., 1970; present investigation) . Nevertheless, mimicking of 5-HT inhibitory effects on neurones in some brain areas may explain some of the actions of these drugs; this possibility is not incompatible with the findings of antagonism of 5-HT excitation in other areas.
It seemed possible that the 5-HT-mimicking effects of the tryptamine derivatives observed in the present study might be due to release of 5-HT from terminals around the neurones being studied. The responses to the most potent 5-HT mimicker, 5-MeOT, were therefore examined in rats, which had been pretreated with reserpine or PCPA to deplete 5-HT levels. In both these groups the actions of 5-MeOT were the same as in untreated rats, and it thus appears that these actions were unlikely to be due to release of 5-HT, but were due to a direct action on 5-HT receptors.
We would suggest that the effects of indoletype psychotomimetics on perception and arousal levels depend at least partly on their ability to antagonize the excitatory actions of 5-HT in the pons and medulla.
Methylated derivatives of tryptamine and 5-hydroxytryptamine, including those whose actions are described in this paper, have been suggested as possible endogenous psychotogenic agents. DMT, bufotenine and 5-MeODMT have been detected in higher levels in blood and urine samples from cases of acute schizophrenia than in samples from non-schizophrenics or chronic schizophrenics (Fischer & Spatz, 1970; Tanimukai, Ginther, Spaide, Bueno & Himwich, 1970 ; Narasimhachari, Heller, Spaide, Haskovec, Fujimori, Tabushi & Himwich, 1971; Narasimhachari, Heller, Spaide, Haskovec, Meltzer, Strahilevitz & Himwich, 1971 ). An enzyme capable of synthesizing N,N-dimethylated tryptamines from tryptamine or 5-HT has been demonstrated in rat brain and in human brain (Mandell, Buckingham & Segal, 1971; Saavedra & Axelrod, 1972) ; the O-methylation of 5-hydroxytryptamine in the pineal body is well known (Axelrod & Weissbach, 1961) , and recently, Green, Koslow & Costa (1973) demonstrated the presence in rat hypothalamus of 5-MeOT, apparently originating outside the pineal, since pinealectomy had little effect on the brain concentrations. 5-MeOT may also be the compound present in the B-type monoamine neurones described by Bjorklund, Falck & Steveni (1971) . It therefore seems possible that the hallucinogenic compounds studied in this investigation may be produced in the brain, and may be of importance in the aetiology of schizophrenia.
